CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

CDMO Subsection

Insights into the latest developments in CDMO services and manufacturing.

Continue reading

Injectables Subsection

Expert perspectives on the evolving needs of injectable therapies and packaging.

Continue reading

Nasal & Pulmonary Subsection

Exploring the latest developments in inhalation technologies, respiratory delivery and sustainability

Continue reading

Advertisement

CPHI Milan
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Lifecore Biomedical

Advertisement

Solstice
News

iiCON Supports New Phase II Trial of Novel Pneumococcal Vaccine

The Infection Innovation Consortium: iiCON is managing a new £3.2 million Medical Research Council funded trial to enable progress into development of a new vaccine ...
Continue Reading →
News

AstraZeneca Announces $3.5bn US Investment to Boost Research and Manufacturing

AstraZeneca (AZ) has announced a $3.5bn investment in the US aimed at expanding its research and manufacturing footprint by 2026. The funds will go towards a ...
Continue Reading →
Volume 16 Issue 2

Alleviating Regulatory Burden Through Access Consortium 

While regulatory authorities are in- creasingly adopting reliance programs to assess applications, few offer the opportunity to take advantage of simultaneous assess...
Continue Reading →
Volume 16 Issue 2

Integrating Medical Devices into Pharmacovigilance Portfolios   

How to Navigate the Latest EU Medical Device Regulatory Landscape to Successfully Adapt your Pharma Portfolio Understanding medical device regulations is essentia...
Continue Reading →
Volume 16 Issue 2

Engaging Minority Communities: Collaborative Practises and Long-Term Success  

The quest to understand and treat rare diseases poses unique challenges. Rare diseases, often referred to as orphan diseases, affect a small percentage of the popula...
Continue Reading →
Volume 16 Issue 2

Why X-ray Inspection is a Viable Quality Assurance Solution for Pharma Products 

We are all aware that the pharmaceutical industry operates within a highly regulated environment, where upholding product safety and quality is paramount. Manufactur...
Continue Reading →
Volume 16 Issue 2

Adaptive, Innovative and Future-Ready: How CDMOs are Staying Sharp 

As the pharma and biotech sector navigates economic uncertainties and evolving customer demands, the contract development and manufacturing industry is undergoing a ...
Continue Reading →
Volume 16 Issue 2

Child Resistant Closures: Exploring New Paths Between Safety and Accessibility   

In the intricate and highly regulated landscape of the pharmaceutical industry, patient safety is an aspect that unequivocally stands out in its importance. A corner...
Continue Reading →
Volume 16 Issue 2

Advancements in Pharmaceutical Packaging: Exploring Innovations in Sachet and Stick Pack Design 

In the dynamic field of pharmaceutical packaging, research laboratories play a crucial role in advancing technology and optimising solutions for various packaging fo...
Continue Reading →
Volume 16 Issue 2

Navigating the TGA’s Requirements for Combination Products

Combination products are integral to the healthcare system and play an increasingly important role in patient safety and medicinal usability, enhancing therapeutic b...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Tjoapack
Aptar – 08/01/2026